Website profile

Biopharma Apac

Stay informed on the latest biopharmaceutical news, trends, and developments in Asia Pacific with BioPharma APAC. BioPharma Asia ( APAC ) provides in-depth analysis, insights, and expert commentary on drug development, regulatory updates, and industry partnerships in the region.

  • 301articles · 90d
  • 2+ day agolatest article
  • Jun 15, 2026earliest in window
  • 93%with images
  • 274avg words
articles per day
Categories
  • Medical 185
  • Health & Wellness 156
  • Business & Industrial 121
  • Economy, Business & Finance 121
  • Health 93
  • Science & Technology 81
  • Science & Nature 63
  • Finance & Business 32

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BioPharma APAC
biopharmaapac.com > news > 73 > 8178 > q32-bio-reports-positive-phase-2a-results-for-bempikibart-in-severe-alopecia-areata-plans-pivotal-programme.html

Q32 Bio Reports Positive Phase 2a Results for Bempikibart in Severe Alopecia Areata, Plans Pivotal Programme

1+ mon, 4+ week ago   (280+ words) 15 July 2026 | Wednesday | News -- Clinically meaningful efficacy data on the primary endpoint was observed with a mean percent reduction in SALT score from baseline of 35.3% in the prespecified mITT analysis -- -- 40.0% of patients achieved SALT-20 response at Week 36 in the mITT analysis…...